The Ministry of Health will meet again this Friday afternoon with the autonomous communities to update the vaccination strategy, since the AstraZeneca doses will not be inoculated to people over 65 years of age. Health had already confirmed yesterday that those over 80 will not receive this vaccine and only those with messenger RNA will be injected. Sources close to the plan assure elDiario.es that its administration to those over 65 years of age is also ruled out, and even this Friday its administration to all those over 55 years of age could be ruled out.
These changes in the plan will unleash developments in immunization priority groups, which until now were residential residents and workers and front-line health workers. In this Thursday’s session of the Public Health Commission, it was agreed that the AstraZeneca vaccine, which begins to arrive this weekend, will be injected first to active health and social health professionals not included in the previous groups ( 2 and 3).RELATED
Given the current situation of vaccine availability, the large population group made up of those over 65 could find themselves only with the BioNTech-Pfizer and Moderna vaccines, of which very few doses are arriving. The vaccine developed by the pharmaceutical company AstraZeneca in collaboration with the University of Oxford is especially promising to advance immunization because it does not require storage in deep freezing or handling as complicated as that of Pfizer.
For his part, Fernando Simón, director of the Center for the Coordination of Health Alerts and Emergencies, was quite confident this Thursday at a press conference that the vaccination schedule would not vary too much if the planned deliveries with the pharmaceutical companies are met. “I believe that it is not necessary to readjust the calendars much, what can happen is that two of the groups to be vaccinated can be vaccinated concomitantly at some point,” said Simón, who has avoided going into details. “If deliveries are maintained as planned and the increases in deliveries that are planned in the coming weeks, the truth is that we would have the capacity to meet these objectives,” said the expert in relation to the 70% of the vaccinated population that it is planned for the end of summer. The Minister of Health, Carolina Darias, announced yesterday that the communities will receive 1,810,575 doses of AstraZeneca this February.
Simón also wanted to make it clear that all the doubts about the vaccine are due to the lack of a population sample in the trials. “It is not a question that it is not effective in these groups, but that there is no evidence that it is,” insisted the epidemiologist. Most European countries, including Germany, France and Italy, have also decided not to use these vaccines with those over 65 years of age. The UK, however, is doing so.